Home/Filings/3/A/0001493152-19-002126
3/A//SEC Filing

Browston Trading Ltd 3/A

Accession 0001493152-19-002126

CIK 0001661053other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:15 PM ET

Size

4.9 KB

Accession

0001493152-19-002126

Insider Transaction Report

Form 3/AAmended
Period: 2019-02-14
Holdings
  • Common Stock

    (indirect: See footnote)
    4,443,569
Footnotes (3)
  • [F1]Reflects a 1-for-2 reverse stock split of the Issuer's common stock effected on December 14, 2017.
  • [F2]These shares are owned directly by Biodyne Holding, S.A., 96% of which is owned by Mr. Zhivilo and the reporting person. Mr. Zhivilo and the reporting person are indirect beneficial owners of the reported securities. The reporting person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]This amendment to Form 3 is being filed by the reporting person to correct the number of shares held by Biodyne Holding, S.A. on the initial reporting date.

Documents

1 file

Issuer

Hancock Jaffe Laboratories, Inc.

CIK 0001661053

Entity typeother
IncorporatedCyprus

Related Parties

1
  • filerCIK 0001730736

Filing Metadata

Form type
3/A
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:15 PM ET
Size
4.9 KB